ArriVent BioPharma, Inc. (AVBP) SEC filings
AVBP SEC filings moved a median of -1.17% by the close. AVBP SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the AVBP overview →
49 measured AVBP SEC filing events.
Where these AVBP SEC filings landedvs 49 measured AVBP SEC filing reactions
| Middle 50% of AVBP SEC filing reactions | -4.81% to +0.11% |
|---|---|
| Median reaction (to close) | -1.17% |
| Measured reactions | 49 |
Point-in-time · zero look-ahead
Half of the 49 AVBP SEC filing events with a measured close landed between -4.81% and +0.11%; 33% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K ArriVent BioPharma, Inc. For: Oct 12 | SEC filing · Form 8-K | +0.12% | -1.17% | |
| Form 8-K ArriVent BioPharma, Inc. For: Oct 06 | SEC filing · Form 8-K | -2.87% | +25.44% | |
| Form 10-Q ArriVent BioPharma, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.03% | -2.38% | |
| Form 8-K ArriVent BioPharma, Inc. For: Aug 11 | SEC filing · Form 8-K | +0.03% | -2.38% | |
| Form 8-K ArriVent BioPharma, Inc. For: Jun 18 | SEC filing · Form 8-K | +1.80% | +3.81% | |
| Form 10-Q ArriVent BioPharma, Inc. For: Mar 31 | SEC filing · Form 10-Q | -3.77% | +2.04% | |
| Form 8-K ArriVent BioPharma, Inc. For: May 11 | SEC filing · Form 8-K | -3.77% | +2.04% | |
| Form ARS ArriVent BioPharma, Inc. For: Dec 31 | SEC filing · Form ARS | -0.80% | +0.64% | |
| Form DEF 14A ArriVent BioPharma, Inc. For: Jun 18 | SEC filing · Form DEF | -0.80% | +0.64% | |
| Form DEFA14A ArriVent BioPharma, Inc. | SEC filing · Form DEFA14A | -0.80% | +0.64% | |
| Form 8-K ArriVent BioPharma, Inc. For: Mar 17 | SEC filing · Form 8-K | -2.18% | -7.84% | |
| Form 10-K ArriVent BioPharma, Inc. For: Dec 31 | SEC filing · Form 10-K | -0.79% | -7.79% | |
| Form 8-K ArriVent BioPharma, Inc. For: Mar 05 | SEC filing · Form 8-K | -0.79% | -7.79% | |
| Form S-8 ArriVent BioPharma, Inc. | SEC filing · Form S-8 | -0.79% | -7.79% | |
| Form 10-Q ArriVent BioPharma, Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.27% | -0.38% | |
| Form 8-K ArriVent BioPharma, Inc. For: Nov 10 | SEC filing · Form 8-K | -0.27% | -0.38% | |
| Form 8-K ArriVent BioPharma, Inc. For: Sep 09 | SEC filing · Form 8-K | +0.89% | -1.98% | |
| Form 10-Q ArriVent BioPharma, Inc. For: Jun 30 | SEC filing · Form 10-Q | -2.30% | -4.61% | |
| Form 8-K ArriVent BioPharma, Inc. For: Aug 11 | SEC filing · Form 8-K | -2.30% | -4.61% | |
| Form 8-K ArriVent BioPharma, Inc. For: Jul 21 | SEC filing · Form 8-K | +1.13% | -2.93% | |
| Form 8-K ArriVent BioPharma, Inc. For: Jul 01 | SEC filing · Form 8-K | -3.54% | -2.03% | |
| Form 8-K ArriVent BioPharma, Inc. For: Jun 23 | SEC filing · Form 8-K | +1.01% | -7.88% | |
| Form 8-K ArriVent BioPharma, Inc. For: Jun 18 | SEC filing · Form 8-K | +1.01% | -7.88% | |
| Form 10-Q ArriVent BioPharma, Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.67% | -4.81% | |
| Form 8-K ArriVent BioPharma, Inc. For: May 12 | SEC filing · Form 8-K | +4.14% | -0.79% | |
| Form 8-K ArriVent BioPharma, Inc. For: Apr 23 | SEC filing · Form 8-K | -1.65% | -0.10% | |
| Form ARS ArriVent BioPharma, Inc. For: Dec 31 | SEC filing · Form ARS | -1.22% | +0.05% | |
| Form DEF 14A ArriVent BioPharma, Inc. For: Jun 18 | SEC filing · Form DEF | -1.22% | +0.05% | |
| Form DEFA14A ArriVent BioPharma, Inc. | SEC filing · Form DEFA14A | -1.22% | +0.05% | |
| Form 8-K ArriVent BioPharma, Inc. For: Mar 11 | SEC filing · Form 8-K | +0.00% | -3.98% | |
| Form 10-K ArriVent BioPharma, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.17% | -6.45% | |
| Form 8-K ArriVent BioPharma, Inc. For: Mar 03 | SEC filing · Form 8-K | +0.17% | -6.45% | |
| Form S-8 ArriVent BioPharma, Inc. | SEC filing · Form S-8 | +0.17% | -6.45% | |
| Form S-3ASR ArriVent BioPharma, Inc. | SEC filing · Form S-3ASR | +0.74% | -0.72% | |
| Form 8-K ArriVent BioPharma, Inc. For: Jan 21 | SEC filing · Form 8-K | +0.42% | +2.82% | |
| Form 10-Q ArriVent BioPharma, Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.32% | -11.34% | |
| Form 8-K ArriVent BioPharma, Inc. For: Nov 14 | SEC filing · Form 8-K | -0.32% | -11.34% | |
| Form 8-K ArriVent BioPharma, Inc. For: Sep 09 | SEC filing · Form 8-K | -0.48% | -7.38% | |
| Form 10-Q ArriVent BioPharma, Inc. For: Jun 30 | SEC filing · Form 10-Q | -0.25% | -0.83% | |
| Form 8-K ArriVent BioPharma, Inc. For: Aug 14 | SEC filing · Form 8-K | -0.25% | -0.83% | |
| Form 8-K/A ArriVent BioPharma, Inc. For: Apr 20 | SEC filing · Form 8-K | +0.00% | -3.65% | |
| Form 8-K/A ArriVent BioPharma, Inc. For: May 16 | SEC filing · Form 8-K | +0.00% | -3.65% | |
| Form 8-K ArriVent BioPharma, Inc. For: Jun 04 | SEC filing · Form 8-K | +0.27% | +0.11% | |
| Form 8-K ArriVent BioPharma, Inc. For: May 16 | SEC filing · Form 8-K | +0.00% | -3.60% | |
| Form 10-Q ArriVent BioPharma, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +3.21% | |
| Form 8-K ArriVent BioPharma, Inc. For: May 08 | SEC filing · Form 8-K | +0.00% | +3.21% | |
| Form 8-K ArriVent Biopharma, Inc. For: Apr 20 | SEC filing · Form 8-K | — | -0.82% | |
| Form 10-K ArriVent Biopharma, Inc. For: Dec 31 | SEC filing · Form 10-K | +1.45% | +2.18% | |
| Form 8-K ArriVent Biopharma, Inc. For: Mar 28 | SEC filing · Form 8-K | +1.45% | +2.18% |
Keep exploring
More AVBP: earnings → · analyst actions → · AVBP overview →